Evaluation of the Drug-Resistant Tuberculosis (DR-TB) Management Component Under the National Tuberculosis Elimination Program (NTEP) in Kerala, India, 2021-22

Overview

Journal Lung India

Specialty Pulmonary Medicine

Date 2024 Dec 24

PMID 39718911

Authors

Raman Swathy Vaman

Madhanraj Kalyanasundaram

Malu Mohan

Narayana Pradeepa

Manoj V Murhekar

Affiliations

Soon will be listed here.

Abstract

Background And Objective: We evaluated the DR-TB component of the National Tuberculosis Elimination Program (NTEP) in a high-burden district in Kerala to identify the programmatic gaps, if any, in screening, diagnosis, treatment, and follow-up of notified DR-TB patients.

Methods: A mixed-methods design was used, and the evaluation was performed in two steps. In the first step, we reviewed the program documents and conducted stakeholder interviews to develop a detailed description of the program design and developed a logical framework to evaluate program performance. Consequently, in the next step, we conducted programmatic data reviews, facility surveys, and in-depth interviews with key stakeholders to identify the programmatic gaps in implementation, guided by the logic framework.

Results: Of the 494 microbiologically confirmed TB patients during 2021-22, 342 (69%) were tested for drug sensitivity, and 30 DR-TB patients were identified. There was no separate district DR-TB treatment center with airborne infection control facilities, and only 16% (66/422) of the various categories of staff were trained in recent guidelines. Only 30% (9/30) of DR-TB patients were provided with any psychological assessment. The favorable treatment outcome was 80% Interviews revealed poor readiness and motivation from the private sector for screening, contextual barriers in human resource availability, transportation, and financial barriers to the beneficiary despite providing financial benefits.

Conclusion: Prioritizing the establishment of a district DR-TB treatment center and sputum transport mechanism, posting a clinical psychologist dedicated to counseling patients on therapy, and training all categories of staff on DR-TB management guidelines will significantly contribute to improving program outcomes.

References

Khanna A, Saha R, Ahmad N . National TB elimination programme - What has changed. Indian J Med Microbiol. 2022; 42:103-107. PMC: 9672688. DOI: 10.1016/j.ijmmb.2022.10.008. View

Shivekar S, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Vidya Raj C, Alagappan C . Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep. 2020; 10(1):17552. PMC: 7567814. DOI: 10.1038/s41598-020-74432-y. View

Visca D, Zampogna E, Sotgiu G, Centis R, Saderi L, DAmbrosio L . Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2019; 53(3). DOI: 10.1183/13993003.02184-2018. View

Balakrishnan S, Ps R, M S, Sankar B, Ramachandran R, Ka A . STEPS: A Solution for Ensuring Standards of TB Care for Patients Reaching Private Hospitals in India. Glob Health Sci Pract. 2021; 9(2):286-295. PMC: 8324185. DOI: 10.9745/GHSP-D-20-00449. View

Velayutham B, Jayabal L, Watson B, Jagadeesan S, Suresh C, Nair D . Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India. Indian J Community Med. 2023; 48(1):103-107. PMC: 10112748. DOI: 10.4103/ijcm.ijcm_315_22. View

Salodia U, Sethi S, Khokhar A . Depression among tuberculosis patients attending a DOTS centre in a rural area of Delhi: A cross-sectional study. Indian J Public Health. 2019; 63(1):39-43. DOI: 10.4103/ijph.IJPH_109_18. View

Singh S, Naaraayan A, Acharya P, Menon B, Bansal V, Jesmajian S . Pulmonary Rehabilitation in Patients with Chronic Lung Impairment from Pulmonary Tuberculosis. Cureus. 2019; 10(11):e3664. PMC: 6364956. DOI: 10.7759/cureus.3664. View

. Framework for program evaluation in public health. MMWR Recomm Rep. 1999; 48(RR-11):1-40. View

Rouf A, Masoodi M, Dar M, Khan S, Bilquise R . Depression among Tuberculosis patients and its association with treatment outcomes in district Srinagar. J Clin Tuberc Other Mycobact Dis. 2021; 25:100281. PMC: 8637130. DOI: 10.1016/j.jctube.2021.100281. View

10.

Hussain A, Khurana A, Goyal A, Kothari S, Soman R, Tej S . Effect of pulmonary rehabilitation in patients with post-tuberculosis sequelae with functional limitation. Indian J Tuberc. 2024; 71(2):123-129. DOI: 10.1016/j.ijtb.2023.04.012. View

11.

Jeyashree K, Shanmugasundaram P, Shanmugasundaram D, Priya G S, Thangaraj J, Ts S . Direct benefit transfer for nutritional support of patients with TB in India-analysis of national TB program data of 3.7 million patients, 2018-2022. BMC Public Health. 2024; 24(1):299. PMC: 10811802. DOI: 10.1186/s12889-024-17777-7. View

12.

Thakkar D, Piparva K, Lakkad S . A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India. 2019; 36(2):108-111. PMC: 6410600. DOI: 10.4103/lungindia.lungindia_86_18. View

13.

Chen A, Kumar R, Baria R, Shridhar P, Subbaraman R, Thies W . Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study. BMC Infect Dis. 2023; 23(1):504. PMC: 10391893. DOI: 10.1186/s12879-023-08418-2. View

14.

Muniyandi M, Thomas B, Karikalan N, Kannan T, Rajendran K, Saravanan B . Association of Tuberculosis With Household Catastrophic Expenditure in South India. JAMA Netw Open. 2020; 3(2):e1920973. PMC: 11845097. DOI: 10.1001/jamanetworkopen.2019.20973. View

15.

Solanki N, Upadhyay A, Upadhyay R, Dabar D, Mandal U, Yadav V . A Cross-Sectional Study on the Prevalence of Depression and Associated Factors in Tuberculosis Patients in the Vidisha District of Madhya Pradesh, India. Cureus. 2023; 15(10):e46637. PMC: 10627115. DOI: 10.7759/cureus.46637. View